Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 3 ( May-June, 2019 ) > List of Articles


Prevalence of Polycystic Ovarian Syndrome in Iranian Adolescents: A Systematic Review and Meta-analysis

Ashraf Ghiasi

Keywords : Adolescence, Polycystic ovarian syndrome, Systematic review

Citation Information : Ghiasi A. Prevalence of Polycystic Ovarian Syndrome in Iranian Adolescents: A Systematic Review and Meta-analysis. J South Asian Feder Obs Gynae 2019; 11 (3):194-197.

DOI: 10.5005/jp-journals-10006-1681

License: CC BY-NC 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2019; The Author(s).


Objective: Polycystic ovarian syndrome (PCOS) is an endocrine disorder that frequently manifests during adolescence. The studies performed in Iran have reported a different prevalence of PCOS in adolescents. Therefore, the aim of this systematic review and meta-analysis study was to estimate the pooled prevalence of PCOS in Iranian adolescents. Materials and methods: An electronic search was performed using Web of Science, PubMed, Scopus, Magiran, SID, and also search engine of Google Scholar from inception until November 2018 to identify published papers on the prevalence of PCOS in Iranian adolescents. Of 458 articles that were assessed for eligibility with the PRISMA statement, a total of 8 studies met inclusion criteria. Data were analyzed using Review Manager Software (RevMan v5.3). Results: The included studies in the review involved 12,796 participants, with a minimum of 895 and a maximum of 3,190. Pooled estimates revealed that the prevalence of PCOS in Iranian adolescents according to the NIH criteria and Rotterdam criteria were 3% (95% CI: 2–4%), and 7% (95% CI: 6–8%) respectively. Conclusion: Considering the significant effect of PCOS on fertility and public health of women, interventions for prevention, diagnosis, and management of this syndrome from adolescence are necessary.

  1. Brady C, Mousa SS, et al. Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf 2009;1:9–15. DOI: 10.2147/DHPS.S4388.
  2. McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med 2016;375(1):54–64. DOI: 10.1056/NEJMcp1514916.
  3. Mohammad MB, Majdi Seghinsara A. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH. Asian Pac J Cancer Prev 2017;18(1):17–21. DOI: 10.22034/APJCP.2017.18.1.17.
  4. Sermons SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013;6:1–13. DOI: 10.2147/CLEP.S37559.
  5. Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011;4(2):45–51.
  6. Singh A, Vijaya K, et al. Prevalence of polycystic ovarian syndrome among adolescent girls: a prospective study. Int J Reprod Contracept Obstet Gynecol 2018;7(11):4375–4378. DOI: 10.18203/2320-1770.ijrcog20184230.
  7. Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr 2017;6(4): 248–255. DOI: 10.21037/tp.2017.09.11.
  8. American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee. American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. Endocr Pract 2005;11(2):126–134.
  9. Moran LJ, Misso ML, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010;16(4):347–363. DOI: 10.1093/humupd/dmq001.
  10. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 2005;34(3):677–705. DOI: 10.1016/j.ecl.2005.04.005.
  11. Vandenbroucke JP, von Elm E, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007;18(6):805–835. DOI: 10.1097/EDE.0b013e3181577511.
  12. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
  13. Hashemipour M, Faghihimani S, et al. Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Esfahan, Iran. Horm Res 2004;62(6):278–282.
  14. Naghash Hoseini SH. The prevalence of PCOS in Kerman final high school 1000 girls 18–15 years old. School of Medicine, Kerman University of Medical Sciences and Health Services; 2008;1(4):112–116.
  15. Rahmanpour H, Heidari R, et al. The prevalence of polycystic ovarian syndrome in 14–18 year old girls of Zanjan High Schools, 2008. J Zanjan Univ Med Sci 2009;67(17):79–87.
  16. Salehpour S, Esmaeilnia Shirvani H, et al. Evaluation of the Prevalence of Polycystic Ovarian Syndrome among Adolescent (15–18 Years Old) Girls in Tehran during 2005–2006. Int J Fertil Steril 2010;4(3):122–127.
  17. Nadri T, Akbarzadeh M, et al. The prevalence of polycystic ovary syndrome phenotypes in girls’ high school (2009). J Qazvin Univ Med Sci 2010;4(61):61–67.
  18. Noorbala MT, Kefaie P. The Prevalence of Hirsutism in Adolescent Girls in Yazd, Central Iran. Iran Red Crescent Med J 2010;12(2):111–117.
  19. Asgharnia M, Mirblook F, et al. The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria. Int J Fertil Steril 2011;4(4):156–159.
  20. Esmaeilzadeh S, Delavar MA, et al. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health 2014;26(4):559–565. DOI: 10.1515/ijamh-2013-0335.
  21. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Dunaif A, Givens JR, et al. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992. pp. 377–384.
  22. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25. DOI: 10.1016/j.fertnstert.2003.10.004.
  23. Jalilian A, Kiani F, et al. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a meta-analysis. Iran J Reprod Med 2015;13(10):591–604.
  24. Nidhi R, Padmalatha V, et al. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011;24(4):223–227. DOI: 10.1016/j.jpag.2011.03.002.
  25. Kaewnin J, Vallibhakara O, et al. Prevalence of polycystic ovary syndrome in Thai University adolescents. Gynecol Endocrinol 2018;34(6):476–480. DOI: 10.1080/09513590.2017.1409716.
  26. Christensen SB, Black MH, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013;100(2):470–477. DOI: 10.1016/j.fertnstert.2013.04.001.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.